2022 Speakers

Allison Goldfine

Director, Translational Medicine Cardiometabolic Disease

Novartis

Andrew Billin

Senior DirectorBiomarker Sciences

Gilead

Anjali Pandey

Senior Vice PresidentNonclinical R&D & Chemistry

AriaPharmaceuticals

Arvid Söderhäll

Chief Executive Officer

Empros Pharma

Ashish Nimgaonkar

Founder & Chief Executive Officer

Glyscend

Clare Buckeridge

Clinical LeadInternal Medicine Research Unit

Pfizer

Cynthia Arbeeny

Chief Scientific Officer

Mitotherapeutix

George Kemble

Chief Executive Officer

Sagimet Biosciences

Ginnie (Hsiu-Chiung) Yang

Vice President, Therapeutic Area 2, Inflammation, Exploratory Pathobiology, Tissue Repair

Bayer

Helen Heymann

Senior Scientific Project Manager, Metabolic Disorders

Foundation for the National Institutes of Health

Henry Hsu

Chief Executive Officer

Allysta Pharmaceuticals

Jacob Jeppesen

Vice President Type 2 Diabetes & Cardiovascular Disease Research

Novo Nordisk

Jim Perfield

Executive Director Discovery Biology, Diabetes, Obesity & Complications

Eli Lilly & Company

Kitty Yale

Chief Development Officer

Akero Therapeutics

Leigh MacConell

Chief Development Officer

HighTide Therapeutics

Marc Thibonnier

Founder & President

AptamiR Therapeutics

Margaret Koziel

Chief Medical Officer

Axcella Therapeutics

Mathijs Bunck

Associate Vice President, Medical Development, Tirzepatide Obesity

Eli Lilly & Company

Michael Cooreman

Chief Medical Officer

Inventiva Pharma

Michelle Long

International Medical Vice President, NASH

Novo Nordisk

Minjun Chen

Staff Fellow Division of Bioinformatics & Biostatistics

FDA

Morten Karsdal

Chief Executive Officer

Nordic Bioscience

Nezam Afdhal

Chief of the Division of Gastroenterology Hepatology & Nutrition

Nutrition Beth Israel Deaconess Medical Center

Pascaline Clerc

Vice President of Global External Affairs

Inventiva Pharma

Paulo Fontes

Co-Founder & Chief Medical Officer

LyGenesis

Phil Ambery

Global Clinical Head, CVRM

AstraZeneca

Pol Boudes

Chief Medical Officer

Galectin Therapeutics

Quin Wills

Co-Founder & Chief Scientific Officer

Ochre Bio

Ramy Younes

Senior Clinical Program Leader NASH & Obesity

Boehringer Ingelheim

Ranabir SinhaRoy

Vice President & Global Program Head General Medicine

Regeneron

Rebecca Taub

Founder & Chief Medical Officer

Madrigal Pharmaceuticals

Richard Torstenson

Senior Director Global Regulatory Affairs

AstraZeneca

Salah Kivlighn

Chief Executive Officer

HepaTx

Sarah Sherlock

Senior Director, Clinical & Translational Imaging & Head of External Imaging Alliances

Pfizer

Scott Harris

Chief Medical Officer

Altimmune

Scott Kelly

Chief Medical Officer

CytoDyn

Stan Watowich

Founder & Chief Executive Officer

Ridgeline Therapeutics

Stephanie Venn- Watson

Co-Founder & Chief Executive Officer

Epitracker

Sudha Shankar

Global Clinical Head NASH

AstraZeneca